Medtronic (MDT) Outperforms Broader Market: What You Need to Know

Impact · against what's priced in

The article contains no new catalysts for Medtronic, as the cited revenue and EPS estimates align exactly with the figures the market has already priced in for the fiscal year.

MDT+0.00

Already priced in

The price assumes

Fiscal 2027 organic revenue growth of 7.25%–7.75% and non-GAAP EPS of $5.94–$6.00

The article's projected full-year revenue of $38.96 billion (7.14%) and EPS of $5.98 are consistent with the guidance the market is already paying for.

What MDT's price assumes · Sep 9

• earnings
• fundamental analysis
• healthcare
• revenue growth
• MDT
• eps
• medical devices

Search tags